When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives

Varying estimates of the cost-effectiveness of genomic testing applications can reflect differences in study questions, settings, methods and assumptions. This review compares recently published cost-effectiveness analyses of testing strategies for Lynch Syndrome (LS) in tumors from patients newly d...

Descripción completa

Detalles Bibliográficos
Autor principal: Grosse, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604059/
https://www.ncbi.nlm.nih.gov/pubmed/26473097
http://dx.doi.org/10.3390/healthcare3040860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604059/
https://www.ncbi.nlm.nih.gov/pubmed/26473097
http://dx.doi.org/10.3390/healthcare3040860

Ejemplares similares